An Overview of the Impact of Pharmaceuticals on Aquatic Microbial Communities

Pharmaceuticals are present as pollutants in several ecosystems worldwide. Despite the reduced concentrations at which they are detected, their negative impact on natural biota constitutes a global concern. The consequences of pharmaceuticals’ presence in water sources and food have been evaluated w...

Full description

Bibliographic Details
Main Authors: Isabel Pinto, Manuel Simões, Inês B. Gomes
Format: Article
Language:English
Published: MDPI AG 2022-11-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/11/12/1700
_version_ 1797461805754220544
author Isabel Pinto
Manuel Simões
Inês B. Gomes
author_facet Isabel Pinto
Manuel Simões
Inês B. Gomes
author_sort Isabel Pinto
collection DOAJ
description Pharmaceuticals are present as pollutants in several ecosystems worldwide. Despite the reduced concentrations at which they are detected, their negative impact on natural biota constitutes a global concern. The consequences of pharmaceuticals’ presence in water sources and food have been evaluated with a higher detail for human health. However, although most of the pharmaceuticals detected in the environment had not been designed to act against microorganisms, it is of utmost importance to understand their impact on the environmental native microbiota. Microbial communities can suffer serious consequences from the presence of pharmaceuticals as pollutants in the environment, which may directly impact public health and ecosystem equilibrium. Among this class of pollutants, the ones that have been studied in more detail are antibiotics. This work aims to provide an overview of the impacts of different pharmaceuticals on environmental biofilms, more specifically in biofilms from aquatic ecosystems and engineered water systems. The alterations caused in the biofilm function and characteristics, as well as bacteria antimicrobial tolerance and consequently the associated risks for public health, are also reviewed. Despite the information already available on this topic, the need for additional data urges the assessment of emerging pollutants on microbial communities and the potential public health impacts.
first_indexed 2024-03-09T17:24:35Z
format Article
id doaj.art-f871f5f71ca644f0a0606d720b3b88ee
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-09T17:24:35Z
publishDate 2022-11-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-f871f5f71ca644f0a0606d720b3b88ee2023-11-24T12:52:53ZengMDPI AGAntibiotics2079-63822022-11-011112170010.3390/antibiotics11121700An Overview of the Impact of Pharmaceuticals on Aquatic Microbial CommunitiesIsabel Pinto0Manuel Simões1Inês B. Gomes2LEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, PortugalLEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, PortugalLEPABE—Laboratory for Process Engineering, Environment, Biotechnology and Energy, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465 Porto, PortugalPharmaceuticals are present as pollutants in several ecosystems worldwide. Despite the reduced concentrations at which they are detected, their negative impact on natural biota constitutes a global concern. The consequences of pharmaceuticals’ presence in water sources and food have been evaluated with a higher detail for human health. However, although most of the pharmaceuticals detected in the environment had not been designed to act against microorganisms, it is of utmost importance to understand their impact on the environmental native microbiota. Microbial communities can suffer serious consequences from the presence of pharmaceuticals as pollutants in the environment, which may directly impact public health and ecosystem equilibrium. Among this class of pollutants, the ones that have been studied in more detail are antibiotics. This work aims to provide an overview of the impacts of different pharmaceuticals on environmental biofilms, more specifically in biofilms from aquatic ecosystems and engineered water systems. The alterations caused in the biofilm function and characteristics, as well as bacteria antimicrobial tolerance and consequently the associated risks for public health, are also reviewed. Despite the information already available on this topic, the need for additional data urges the assessment of emerging pollutants on microbial communities and the potential public health impacts.https://www.mdpi.com/2079-6382/11/12/1700antimicrobial resistancebiofilmsecological interactionsemerging contaminantsmicrobial diversityone health
spellingShingle Isabel Pinto
Manuel Simões
Inês B. Gomes
An Overview of the Impact of Pharmaceuticals on Aquatic Microbial Communities
Antibiotics
antimicrobial resistance
biofilms
ecological interactions
emerging contaminants
microbial diversity
one health
title An Overview of the Impact of Pharmaceuticals on Aquatic Microbial Communities
title_full An Overview of the Impact of Pharmaceuticals on Aquatic Microbial Communities
title_fullStr An Overview of the Impact of Pharmaceuticals on Aquatic Microbial Communities
title_full_unstemmed An Overview of the Impact of Pharmaceuticals on Aquatic Microbial Communities
title_short An Overview of the Impact of Pharmaceuticals on Aquatic Microbial Communities
title_sort overview of the impact of pharmaceuticals on aquatic microbial communities
topic antimicrobial resistance
biofilms
ecological interactions
emerging contaminants
microbial diversity
one health
url https://www.mdpi.com/2079-6382/11/12/1700
work_keys_str_mv AT isabelpinto anoverviewoftheimpactofpharmaceuticalsonaquaticmicrobialcommunities
AT manuelsimoes anoverviewoftheimpactofpharmaceuticalsonaquaticmicrobialcommunities
AT inesbgomes anoverviewoftheimpactofpharmaceuticalsonaquaticmicrobialcommunities
AT isabelpinto overviewoftheimpactofpharmaceuticalsonaquaticmicrobialcommunities
AT manuelsimoes overviewoftheimpactofpharmaceuticalsonaquaticmicrobialcommunities
AT inesbgomes overviewoftheimpactofpharmaceuticalsonaquaticmicrobialcommunities